Turn Therapeutics Inc.·4

Apr 3, 8:09 AM ET

BEB Holdings, LLC 4

4 · Turn Therapeutics Inc. · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Turn Therapeutics (TTRX) CEO Bradley Burnam Gifts 300,000 Shares

What Happened

  • Bradley Evan Burnam, CEO of Turn Therapeutics (TTRX), reported a gift (transaction code G) disposing of 300,000 shares on 2026-04-02. The reported price is $0.00, so the disposition value is $0. This was a transfer by gift, not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-04-02; Form 4 filed: 2026-04-03 (timely filing).
  • Transaction type/code: Gift (G); amount disposed: 300,000 shares; reported price: $0.00; reported value: $0.
  • Shares owned after transaction: Not specified in the provided filing.
  • Notable footnote (F1): The shares may be held by BEB Holdings, LLC. Mr. Burnam is the sole member of BEB Holdings, LLC and has sole voting and dispositive power over those shares, so shares held by the LLC may be deemed beneficially owned by him.
  • No indication in this filing of a 10b5-1 plan, tax withholding, option exercise, or late filing.

Context

  • Gifts are a transfer of shares and do not represent a market purchase signal; they generally do not by themselves indicate the insider’s view of the company’s near-term prospects. The filing shows a disposal by gift rather than a sale generating cash.

Insider Transaction Report

Form 4
Period: 2026-04-02
Burnam Bradley Evan
DirectorChief Executive Officer10% Owner
Transactions
  • Gift

    Common Stock

    [F1]
    2026-04-02300,00015,716,260 total(indirect: By LLC)
Footnotes (1)
  • [F1]Represents shares of common stock held by BEB Holdings, LLC. The reporting person is the sole member of BEB Holdings, LLC and has sole voting and dispositive power with regard to the shares held by BEB Holdings, LLC. Accordingly, all shares held by BEB Holdings, LLC may be deemed to be beneficially owned by the reporting person.

Documents

1 file
  • 4
    ownership.xmlPrimary